Table 2.
Miliary Disease | Pulmonary and Extrapulmonary Disease | Extrapulmonary-Only Disease | Cavitary Pulmonary Disease | |
---|---|---|---|---|
Tuberculin test* | ||||
Negative | Reference | Reference | Reference | Reference |
Positive | 0.33 (0.28–0.39) | 0.59 (0.51–0.67) | 1.01 (0.89–1.14) | 0.91 (0.83–1.01) |
IGRA | ||||
Negative | Reference | Reference | Reference | Reference |
Positive | 0.95 (0.73–1.23) | 0.89 (0.75–1.07) | 0.90 (0.78–1.05) | 1.03 (0.89–1.19) |
Indeterminate | 1.98 (1.36–2.87) | 1.47 (1.11–1.96) | 0.96 (0.73–1.25) | 1.11 (0.86–1.43) |
Definition of abbreviation: IGRA = IFN-γ release assay.
Data presented as adjusted odds ratio (95% CI). Models are adjusted for age, sex, HIV status, and birthplace. Noncavitary pulmonary disease, with the largest number of cases, is the referent clinical category. Statistically significant results are represented in bold type.
Tuberculin test negative = 0–4 mm; tuberculin test positive = 5+ mm.